















 Presepsin, which is produced in monocytes via its phagocytosis, is one of the biomarker proteins for 
sepsis, but it is unknown whether other cells secrete presepsin besides monocytes. To clarify the 
mechanism of presepsin production, we studied presepsin production from neutrophils and effects of 
inhibitors of phagocytosis and serine protease. We confirmed that prsepsin levels increased significantly 
when neutrophils were stimulated by Escherichia coli (E. coli). In phagocytosis blocking assay, no 
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cytochalasin D for blocking actin polymerization. In addition, presepsin production of the cells treated 
with serine protease inhibitor were significantly decreased, on the other hand in cells treated neutrophil 
elastase inhibitor, presepsin production were a little suppressed. These results indicate that neutrophils 
as well as monocytes produce presepsin but different pathways from the phagocytosis, and furthermore 
serine proteases other than elastase may be involved in presepsin production.
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